Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 674

1.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

3.

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.

Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J.

Am J Clin Nutr. 2006 Jul;84(1):5-17. Review.

4.

Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.

Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.

Herz. 2004 Nov;29(7):673-85. Review. Erratum in: Herz. 2004 Dec;29(8):805.

PMID:
15580322
5.

Effect of fish oil on arrhythmias and mortality: systematic review.

León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT.

BMJ. 2008 Dec 23;337:a2931. doi: 10.1136/bmj.a2931. Review.

6.

n-3 fatty acids and cardiovascular disease.

Breslow JL.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1477S-1482S. Review.

7.

Cardiovascular disease prevention and treatment.

von Schacky C.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):193-8. doi: 10.1016/j.plefa.2009.05.009. Review.

PMID:
19520557
8.

n-3 fatty acids and cardiovascular events after myocardial infarction.

Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group..

N Engl J Med. 2010 Nov 18;363(21):2015-26. doi: 10.1056/NEJMoa1003603.

9.

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group..

Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Review.

PMID:
22493407
10.

n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.

Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS.

Am J Clin Nutr. 2003 Feb;77(2):319-25.

11.

Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.

Rupp H.

Adv Ther. 2009 Jul;26(7):675-90. doi: 10.1007/s12325-009-0045-2. Review.

PMID:
19629408
13.
14.

Effects of fish-oil supplementation on myocardial fatty acids in humans.

Metcalf RG, James MJ, Gibson RA, Edwards JR, Stubberfield J, Stuklis R, Roberts-Thomson K, Young GD, Cleland LG.

Am J Clin Nutr. 2007 May;85(5):1222-8.

15.
16.

Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.

Holub BJ.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):199-204. doi: 10.1016/j.plefa.2009.05.016. Review.

PMID:
19545988
17.

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie CJ, Milani RV, Mehra MR, Ventura HO.

J Am Coll Cardiol. 2009 Aug 11;54(7):585-94. doi: 10.1016/j.jacc.2009.02.084. Review.

18.

Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.

Pauwels EK, Kostkiewicz M.

Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Review.

PMID:
19221636
19.

[Omega-3 fatty acids in cardiology. Latest developments].

von Schacky C.

MMW Fortschr Med. 2007 Sep 13;149 Suppl 3:97-101. Review. German.

PMID:
17955786
20.

Omega-3 fatty acids vs. cardiac disease--the contribution of the omega-3 index.

Von Schacky C.

Cell Mol Biol (Noisy-le-grand). 2010 Feb 25;56(1):93-101.

PMID:
20196973
Items per page

Supplemental Content

Support Center